Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | RAD52 | P43351 | 1/20 | 0.36 |
| ▸ | HTR2C | P28335 | 9/20 | 0.34 |
| ▸ | GSK3B | P49841 | 4/20 | 0.33 |
| ▸ | LATS1 | O95835 | 1/20 | 0.33 |
| ▸ | ROCK1 | Q13464 | 2/20 | 0.32 |
| ▸ | KCNH2 | Q12809 | 1/20 | 0.32 |
| ▸ | HTR2B | P41595 | 5/20 | 0.31 |
| ▸ | HTR2A | P28223 | 4/20 | 0.31 |
| ▸ | SLC6A2 | P23975 | 1/20 | 0.31 |
| ▸ | SLC6A4 | P31645 | 1/20 | 0.31 |
| ▸ | SLC6A3 | Q01959 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1028438 | 0.68 | SLC6A2 (0.57) | RAD52HTR2CROCK1HTR2BHTR2A | |
| SCHEMBL17884678 | 0.68 | SLC6A2 (0.57) | RAD52HTR2CROCK1HTR2BHTR2A | |
| SCHEMBL17884836 | 0.68 | SLC6A2 (0.57) | RAD52HTR2CROCK1HTR2BHTR2A | |
| Bromide SCHEMBL10498800 | 0.67 | SLC6A2 (0.55) | RAD52HTR2CROCK1HTR2BHTR2A | |
| SCHEMBL22542020 | 0.67 | ADRB1 (0.52) | RAD52HTR2CGSK3BLATS1HTR2B | |
| Hydrochloric Acid SCHEMBL6912062 | 0.67 | SLC6A2 (0.55) | RAD52HTR2CROCK1HTR2BHTR2A | |
| Hydrochloric Acid SCHEMBL21340093 | 0.67 | SLC6A2 (0.55) | RAD52HTR2CROCK1HTR2BHTR2A | |
| SCHEMBL22542046 | 0.67 | ADRB1 (0.52) | RAD52HTR2CGSK3BLATS1HTR2B | |
| Hydrochloric Acid SCHEMBL21340085 | 0.67 | SLC6A2 (0.55) | RAD52HTR2CROCK1HTR2BHTR2A | |
| SCHEMBL4025392 | 0.67 | ADRB1 (0.52) | RAD52HTR2CGSK3BLATS1HTR2B |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11535597-B2 | Photoreactive ligands and uses thereof | THE SCRIPPS RESEARCH INSTITUTE (US) | 2022-12-27 | — | — | US | disclosed |
| US-20200071277-A1 | PHOTOREACTIVE LIGANDS AND USES THEREOF | THE SCRIPPS RESEARCH INSTITUTE | 2020-03-05 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11535597-B2 | Photoreactive ligands and uses thereof | CLTB, CRYAB, CRYAA | RAD52 950/4885HTR2C 2906/4885GSK3B 4422/4885 |
| US-20200071277-A1 | PHOTOREACTIVE LIGANDS AND USES THEREOF | CLTB, CRYAB, CRYAA | RAD52 950/4885HTR2C 2906/4885GSK3B 4422/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.